Status:
COMPLETED
Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies
Lead Sponsor:
Ain Shams University
Conditions:
Twin Pregnancy With Antenatal Problem
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
It is already known that the risk of preterm labor in twin pregnancy before 37 week is 8-9 fold higher compared to singletons, and progesterone supplementation can decrease the incidence of preterm la...
Eligibility Criteria
Inclusion
- Primigravidae
- Twin pregnancies at gestational age 14 week.
- Cervical length more than 2 cm (because if 2cm or less they will undergo cervical cerclage.)
Exclusion
- Polyhydramnios
- Anemia
- Twins with congenital malformation
- Twin to twin transfusion
- Medical diseases as diabetes mellitus, hypertension and systemic lupus erythematosis
- Previous cervical surgery
- High order pregnancy (triples or more)
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04748562
Start Date
January 1 2020
End Date
December 1 2020
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Maternity hospital
Cairo, Egypt